BGMS
Bio Green Med Solution, Inc.
Healthcare — Biotechnology
Bio Green Med Solution, Inc. engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems. It is also involved in research and development of pharmaceuticals. The company was formerly known as Cyclacel Pharmaceuticals, Inc. and changed its name to Bio Green Med Solution, Inc. in September 2022. Bio Green Med Solution, Inc. was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.
None
$0.90
+$0.02 (+2.52%)
Price History
52-Week Range
Sign in to add BGMS to a watchlist or set price alerts.
Fundamentals
| Market Cap | $6.07M |
| P/E Ratio (TTM) | 0.22 |
| Forward P/E | - |
| EPS (TTM) | $5.03 |
| Dividend Yield | - |
| Profit Margin | -204.20% |
| Revenue Growth | - |
| ROE | 20.59% |
| Debt/Equity | - |
| Recommendation | None |
| Analyst Target | - |
| Analysts | - |
| Next Earnings | - |
| Indexes | - |
Technical Indicators
| RSI (14) | 60.9 |
| Beta | -0.38 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $19.87 |
| 52-Week Low | $0.57 |
| 50-Day Avg | $0.95 |
| 200-Day Avg | $1.66 |
| Avg Volume | $2.39M |
| Volume | 349.6K |
Performance Analysis
NEUTRALBGMS presents a mixed picture with both positive and negative indicators.
+
Trading near its 52-week low ($0.57), which could present a value opportunity.
+
RSI at 60.9 shows positive momentum.
-
Price is below both the 50-day and 200-day moving averages — in a downtrend.
+
P/E of 0.2 suggests the stock may be undervalued.
-
Operating at a loss with -204.2% margin.
~
Wall Street consensus is "none".
Recent News
Loading news...
Last updated: Jul 02, 2026 12:59 UTC
Back to Screener Export Report